版本:
中国

浙江华海药业股份有限公司 (600521.SS)

600521.SS ( 上海证券交易所 )

14.09CNY
26 Jun 2019
涨跌 (%)

¥0.14 (+1.00%)
收盘
¥13.95
开盘
¥13.81
当日最高
¥14.18
当日最低
¥13.81
成交量
6,440,126
平均成交量
16,279,489
52 周最高
¥27.80
52 周最低
¥9.80

概况

浙江华海药业股份有限公司是一家主要从事原料药、中间体和成品药生产与销售的中国公司。该公司的主要产品分为普利类、沙坦类和制剂,包括厄贝沙坦片、盐酸帕罗西汀片、利培酮片、福辛普利钠片和厄贝沙坦氢氯噻嗪片等。该公司还提供相关技术服务。该公司于国内市场及海外市场销售其产品。

概况

Beta: 0.80
市值(百万): ¥23,372.63
已发行股本(百万): 1,042.49
股息: 0.18
股息收益率 (%): 0.80

财务指标

  600521.SS Industry Sector
P/E (TTM): 42.74 29.30 32.55
EPS (TTM): 0.52 -- --
ROI: 10.51 14.23 13.82
ROE: 12.79 15.46 15.24

UPDATE 2-FDA approves generic valsartan amid drug shortage

March 12 The U.S. Food and Drug Administration said on Tuesday it had approved a new generic version of blood pressure medicine valsartan, as the agency looks to ease shortages triggered by several manufacturers recalling the drug over possible cancer risk. 全文
03/13 04:38

UPDATE 3-New cancer-causing toxin found in recalled blood pressure pills

March 1 U.S. health regulators said on Friday a third cancer-causing toxin was found in some blood pressure pills recalled by India's Hetero Labs Ltd a day earlier, adding to a global recall of commonly used drugs to treat hypertension. 全文
03/02 07:51

UPDATE 3-New cancer-causing toxin found in recalled blood pressure pills

March 1 U.S. health regulators said on Friday a third cancer-causing toxin was found in some blood pressure pills recalled by India's Hetero Labs Ltd a day earlier, adding to a global recall of commonly used drugs to treat hypertension. 全文
03/02 03:29

CORRECTED-UPDATE 1-New cancer-causing toxin found in recalled blood pressure pills

March 1 U.S. health regulators said on Friday a third cancer-causing toxin was found in some blood pressure pills recalled by India's Hetero Labs Ltd a day earlier, adding to a global recall of commonly-used drugs to treat hypertension. 全文
03/02 00:59

UPDATE 1-Pfizer Japan recalls high blood pressure drug over cancer-causing impurity

TOKYO, Feb 8 The Japanese subsidiary of Pfizer Inc is recalling a drug for high blood pressure which was found to contain a carcinogenic substance in its active ingredient valsartan, the drugmaker said on Friday. 全文
02/08 22:41

More blood pressure drugs may have shortages after recalls -FDA

NEW YORK, Jan 25 Additional shortages of blood pressure drugs in the United States are possible following recent recalls related to traces of a probable carcinogen found in some versions a particular class of hypertension medicines, the U.S. Food and Drug Administration said on Friday. 全文
01/25 22:30

Aurobindo Pharma to recall 80 lots of blood pressure medicine valsartan in the US

Jan 2 A U.S. unit of Indian generic drugmaker Aurobindo Pharma Ltd will recall 80 lots of medicines containing blood pressure drug valsartan that were found to have a probable cancer-causing impurity, according to the U.S. Food and Drug Administration. 全文
01/03 00:41

收益 vs. 预测

姓名 年薪

杜 军

234,700

张 美

260,900

陈 保华

1,500,000

祝 永华

460,000

陈 其茂

470,000